Headway, a subsidiary of China Tongfu (01763), has completed tax payments

Zhitong Finance App News, China Tongpu (01763) issued an announcement. On December 31, 2025, according to the relevant authorities, the company's non-wholly-owned subsidiary, Shenzhen CNNC Headway Biotechnology Co., Ltd. (Headway), should recently pay RMB 188 million in corporate income tax, value-added tax and other taxes and a total of RMB 271 million in late fees from January 1, 2021 to December 31, 2024, mainly involving sales expenses, abnormal inventory losses, etc. during the aforementioned year. As of the date of this announcement, Headway has paid this tax. The tax-related matter is expected to affect the annual profit due to equity shareholders of approximately RMB 130 million in 2025, but the actual financial impact relating to the settlement will depend on the results of the review and review by the company's independent auditors.

Furthermore, the company attaches great importance to the above matters, and will further improve its management capabilities and effectively safeguard the interests of the company and shareholders.